Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,051 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term recurrence risk, metastatic potential and length of cystoscopic surveillance of low-grade non-muscle invasive bladder cancer.
Villegas E, Lajkosz K, Din S, Kuk C, Chan A, Kwong JCC, Vitug C, Gao B, Hemminki O, Kot D, Misurka J, Black P, Jewett M, Soloway MS, Roupret M, Compérat E, Sweet J, Seisen T, Fleshner NE, Wrana J, van der Kwast TH, Kulkarni GS, Zlotta AR. Villegas E, et al. Among authors: roupret m. J Urol. 2024 Oct 29:101097JU0000000000004305. doi: 10.1097/JU.0000000000004305. Online ahead of print. J Urol. 2024. PMID: 39470318
Regional Versus Systematic Biopsy in Addition to Targeted Biopsy: Results from a Systematic Review and Meta-analysis.
Sanguedolce F, Lauwers CNG, Tedde A, Basile G, Chernysheva D, Uleri A, Baboudjian M, Giannarini G, Panebianco V, Madonia M, Budeaus L, Roupret M, Palou J, Breda A, Schoots I, Padhani AR; EAU Section of Urological Imaging (ESUI). Sanguedolce F, et al. Among authors: roupret m. Eur Urol Oncol. 2024 Oct 24:S2588-9311(24)00234-7. doi: 10.1016/j.euo.2024.10.006. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39455339 Free article. Review.
En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Systematic Review and Meta-analysis of Oncological, Histopathological, and Surgical Outcomes.
Basile G, Uleri A, Leni R, Cannoletta D, Afferi L, Baboudjian M, Diana P, D'Andrea D, Teoh J, Pradere B, Subiela JD, Laukhtina E, Seisen T, Rouprêt M, Briganti A, Montorsi F, Moschini M, Breda A, Gallioli A; European Association of Urology—Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. Basile G, et al. Among authors: roupret m. Eur Urol Oncol. 2024 Oct 19:S2588-9311(24)00232-3. doi: 10.1016/j.euo.2024.10.004. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39428278 Review.
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions.
Marandino L, Campi R, Amparore D, Tippu Z, Albiges L, Capitanio U, Giles RH, Gillessen S, Kutikov A, Larkin J, Motzer RJ, Pierorazio PM, Powles T, Roupret M, Stewart GD, Turajlic S, Bex A. Marandino L, et al. Among authors: roupret m. Eur Urol Oncol. 2024 Sep 25:S2588-9311(24)00211-6. doi: 10.1016/j.euo.2024.09.002. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39327187 Free article. Review.
1,051 results